Literature DB >> 29187100

Congenital Heart Defects in Nigerian Children: Preliminary Data From the National Pediatric Cardiac Registry.

Ekanem N Ekure1, Fidelia Bode-Thomas2, Wilson E Sadoh3, Adeola A Orogade4, Barbara E Otaigbe5, Fortune Ujunwa6, Usman M Sani7, Mustafa Asani8, Adeola B Animasahun9, Oluwatoyin O Ogunkunle10.   

Abstract

BACKGROUND: Congenital heart defects (CHDs) are common birth defects with significant impact on morbidity and mortality. We aimed to compare regional patterns of CHDs in Nigeria using a registry-based approach.
METHODS: Children with echocardiography-confirmed CHDs at 17 medical centers across the country were enrolled in a pilot National Pediatric Cardiac Registry from January to December 2014.
RESULTS: A total of 1,296 children (52.9% male; median age 0.9 years) with CHDs were enrolled. Patients enrolled in Northern Nigeria constituted 34.6% of the study population and were older compared to those enrolled from Southern Nigeria (2.9 ± 3.6 vs 2.4 ± 3.5 years; P = .02). Ventricular septal defects were significantly more prevalent in the North (37.4%) compared with the South (18.5%; P < .0001), while severe CHDs were more prevalent in the South ( P = .004). Of the 208 (16.0%) children who received corrective cardiac intervention, only 43 (20.7%) of them had the intervention done in country. More patients in the South received intervention compared to the North (19.02% vs 10.5%; P < .0001).
CONCLUSION: This is the first prospective, registry-based, multicenter study of CHDs in Nigerian children. We demonstrate important differences between the Northern and the Southern geographical regions of the country in terms of age at diagnosis, type, and severity of lesion as well as access to cardiac surgery. The findings demonstrate the utility of a national CHDs registry for understanding clinical epidemiology of CHDs in low- and middle-income countries and its potential to serve as a basis for research and planning.

Entities:  

Keywords:  congenital heart defect; congenital heart disease; disease registry; pediatric

Mesh:

Year:  2017        PMID: 29187100     DOI: 10.1177/2150135117725457

Source DB:  PubMed          Journal:  World J Pediatr Congenit Heart Surg        ISSN: 2150-1351


  5 in total

Review 1.  Genomics and Epigenomics of Congenital Heart Defects: Expert Review and Lessons Learned in Africa.

Authors:  Nicholas Ekow Thomford; Kevin Dzobo; Nana Akyaa Yao; Emile Chimusa; Jonathan Evans; Emmanuel Okai; Paul Kruszka; Maximilian Muenke; Gordon Awandare; Ambroise Wonkam; Collet Dandara
Journal:  OMICS       Date:  2018-05

2.  Study of congenital heart defects among neonates in Jos, Nigeria: prevalence and spectrum.

Authors:  Olukemi O Ige; Tolulope O Afolanranmi; Christopher S Yilgwan; Fanen Ayatse; Esin Nkereuwem; Atiene S Sagay; Phyllis Kanki; Fidelia Bode-Thomas
Journal:  Cardiovasc J Afr       Date:  2021-02-16       Impact factor: 1.167

3.  Pattern of congenital heart disease among children presenting to the Uganda Heart Institute, Mulago Hospital: a 7-year review.

Authors:  Judith Namuyonga; Sulaiman Lubega; Twalib Aliku; John Omagino; Craig Sable; Peter Lwabi
Journal:  Afr Health Sci       Date:  2020-06       Impact factor: 0.927

4.  PROTEA, A Southern African Multicenter Congenital Heart Disease Registry and Biorepository: Rationale, Design, and Initial Results.

Authors:  Thomas Aldersley; John Lawrenson; Paul Human; Gasnat Shaboodien; Blanche Cupido; George Comitis; Rik De Decker; Barend Fourie; Lenise Swanson; Alexia Joachim; Phaphama Magadla; Malebogo Ngoepe; Liam Swanson; Alistair Revell; Raj Ramesar; Andre Brooks; Nicole Saacks; Bianca De Koning; Karen Sliwa; John Anthony; Ayesha Osman; Bernard Keavney; Liesl Zühlke
Journal:  Front Pediatr       Date:  2021-10-20       Impact factor: 3.418

5.  Coagulation abnormalities in children with uncorrected congenital heart defects seen at a teaching hospital in a developing country.

Authors:  Omotola O Majiyagbe; Adeseye M Akinsete; Titilope A Adeyemo; Abideen O Salako; Ekanem N Ekure; Christy A N Okoromah
Journal:  PLoS One       Date:  2022-07-28       Impact factor: 3.752

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.